Artificial intelligence has entered dentistry with remarkable speed. Machine learning systems now assist clinicians in detecting caries, interpreting radiographs, identifying periodontal changes, and screening oral lesions with levels of consistency approaching expert performance. Ethical discussion surrounding dental AI has largely focused on improving prediction accuracy. Clinical medicine recognizes uncertainty as an essential component of responsible diagnosis. This paper argues that responsible AI-assisted dentistry requires recognition of a critical ethical boundary — the moment at which automated diagnostic expression should be intentionally withheld.
Defining algorithmic silence
Algorithmic silence may be defined as the intentional withholding of automated diagnostic recommendation when model confidence, contextual validity, or ethical safety thresholds are not sufficiently satisfied. Silence functions as a designed safeguard embedded within clinical decision-support architecture, allowing uncertainty to become an actionable clinical signal.
Algorithmic silence in oral disease diagnosis
Oral disease diagnosis represents one of the most uncertainty-rich domains of healthcare. AI systems trained on image datasets may perform effectively in advanced disease detection while remaining vulnerable in early or atypical presentations. Calibrated abstention signals prompting referral or further investigation may better protect patients than forced classification.
Responsibility and clinical authority
Continuous algorithmic prediction introduces the risk of responsibility diffusion. Healthcare ethics maintains that the individual who decides bears responsibility. Algorithmic silence helps re-establish accountability by explicitly returning decision authority to the practitioner whenever uncertainty exceeds safe limits.
Algorithmic silence represents an essential evolution in AI-assisted oral healthcare. By embedding uncertainty awareness within clinical systems, dentistry can preserve professional judgment while benefiting from computational intelligence.
References
Amodei D, Olah C, Steinhardt J, et al. Concrete problems in AI safety. arXiv. 2016.
Kelly CJ, Karthikesalingam A, Suleyman M, Corrado G, King D. Key challenges for delivering clinical impact with artificial intelligence. BMC Medicine. 2019;17:195.
Schwendicke F, Samek W, Krois J. Artificial intelligence in dentistry: chances and challenges. Journal of Dental Research. 2020;99(7):769–774.
Floridi L, Cowls J, Beltrametti M, et al. AI4People—An ethical framework for a good AI society. Minds and Machines. 2018;28:689–707.
World Health Organization. Ethics and governance of artificial intelligence for health. Geneva: WHO; 2021.
European Commission. Artificial Intelligence Act. Brussels; 2024.
About the author Dr. Ameed Khalid Abdul-Hamid is an Iraqi–British dental surgeon and academic researcher, internationally recognized for his contributions to artificial intelligence in dentistry and healthcare. He serves as Chairman of the Arab Organisation for Artificial Intelligence in Healthcare and Chairman of the Saudi-British Medical Forum (London). His research focuses on AI-enabled diagnostics, digital health systems, and the ethical, responsible integration of artificial intelligence in clinical care.
Documentation, attribution, and skepticism as clinical safety tools
Defensive medicine used to mean ordering one more test, writing one more line in the note, or documenting that risks were discussed “in detail.” That definition no longer holds. In the AI era, defensive medicine is less about doing more, and more about how decisions were made, who contributed to them, and how uncertainty was handled once artificial intelligence entered the workflow.
The medical record is no longer written by a single clinician at the end of a long shift. It is increasingly co-authored by ambient scribes, summarization engines, clinical decision support tools, and large language models that can sound confident even when they are wrong.
Here is the legal reality clinicians need to absorb early: When AI enters the chart, responsibility does not shift. It concentrates.
A shared workspace, personal liability
Most clinicians already use AI, whether they call it that or not. Ambient documentation, auto-generated assessments, triage tools, record summarization, and literature synthesis are now routine. These tools reduce friction and save time. But they also introduce a new medico-legal problem:
If an AI-generated statement is wrong and it appears in the chart, who owns it?
The law has been consistent so far. The signer owns the note. Courts do not meaningfully distinguish between human-authored and AI-assisted documentation. The medical record remains a clinician’s representation of reality, regardless of how the text was produced. That alone should change how we document.
Photo supplied
Hallucinations are a feature, not a bug
One of the most dangerous myths in healthcare AI is the belief that hallucinations are technical glitches that will be fixed with better models. They will not. Hallucinations are a structural feature of large language models. These systems do not retrieve truth. They generate statistically plausible language based on patterns in prior data.
This behaviour is not accidental. Models are rewarded for producing answers, not for saying “I don’t know.” In fact, any AI model that claims over 75 percent accuracy in a complex system shouldn’t be trusted. It’s probably learning the wrong thing very well.
Language models amplify this risk. They sound authoritative. They write cleanly. They can fabricate references, guidelines, or reasoning unless the reader already knows the answer. In healthcare, fluency without grounding is not neutral. It is dangerous.
Accuracy is not trustworthiness
We are repeatedly told to trust AI because it is “95 percent accurate.” However:
Accuracy is not safety.
Accuracy can hide bias.
Accuracy can ignore uncertainty.
Accuracy can collapse under distribution shifts.
In medicine, what matters is not how often a model is right in aggregate, but how it fails, when it fails, and whether humans can detect that failure in time. Clean metrics do not equal resilient performance.
Photo supplied
“Who (or what) said what” now matters
When AI contributes to clinical reasoning or documentation, attribution becomes a safety tool. Attribution documents judgment. It shows that AI assisted but did not replace reasoning. Years later, that distinction can be very important.
The standard of care is already shifting
Clinicians may be exposed when they use AI and override it, especially after adverse outcomes. This tension has been described as the negative outcome penalty paradox: clinicians can be punished whether they follow or reject AI recommendations once AI becomes normalized. Defensive medicine now requires reasoned positioning, not blind adoption or avoidance.
Defensive documentation needs a major redesign
Traditional defensive documentation emphasized thoroughness; AI-era defensive documentation emphasizes provenance. Practical shifts clinicians should adopt now:
Label AI-assisted content explicitly.
Avoid pasting AI output without review.
Document when AI recommendations were rejected and why.
Be cautious with AI-generated citations and guidelines.
Preserve clinician reasoning, not just summaries.
Training clinicians is now a legal issue
Clinicians do not need to become data scientists, but they do need to understand where hallucinations are most likely, how training data limitations affect output, and why confidence does not equal correctness. Ignorance will not be a defense when AI tools are widely available and increasingly normalized.
Augmented intelligence is the only defensible frame
Augmented intelligence keeps the clinician explicitly in the loop. It reinforces that AI assists but does not decide. The moment AI silently replaces reasoning in documentation, both patient safety and legal defensibility erode. The chart reclaims its original role: a legal narrative of clinical reasoning under uncertainty.
About the author
Dr. Hassan Bencheqroun is a pulmonary and critical care physician, assistant professor at the University of California Riverside School of Medicine, and CEO of Medical AI Academy. He hosts “The AI-Ready Doctor podcast” and is an active AiMed participant and speaker bridging clinical care, education, and technology.
Fig. 1: Agentic AI orchestration across clinical, administrative, regulatory, and patient engagement domains.
The healthcare industry has entered a transformative era. Agentic artificial intelligence — systems capable of autonomous reasoning, planning, and multi-step task execution with defined human oversight — is transitioning from research concept to enterprise deployment.
Unlike traditional machine learning that excels at narrow pattern recognition or generative AI that produces content reactively, agentic AI operates with goal-directed autonomy: decomposing complex objectives, coordinating specialized agents across disparate systems, and adapting strategies based on outcomes. This paradigm shift addresses healthcare’s most persistent challenges, including administrative burden consuming 20 percent of institutional budgets, physician burnout, and the growing complexity of clinical decision-making.1
The acceleration in late 2025 has been remarkable. On December 1, 2025, the U.S. Food and Drug Administration announced agentic AI deployment for all agency employees — the first major regulatory body to institutionalize autonomous AI workflows for administrative functions including meeting management, document processing, and compliance operations.2 Critically, these internal tools support agency operations but do not autonomously render pre-market review decisions. Days later, the Department of Health and Human Services released its comprehensive AI strategy positioning autonomous systems as central to federal health operations.3
Defining the Agentic Paradigm
The distinction between agentic AI and its predecessors is substantive. Traditional machine learning excels at classification within narrow domains. Generative AI expanded to content creation. Agentic AI introduces systems that pursue defined goals with limited supervision, typically employing multiple specialized agents coordinated through an orchestration layer.4
Fig. 2 AI evolution comparison — Traditional AI, Generative AI, and Agentic AI capabilities and interaction modes
Technical precision requires distinguishing workflow automation from true goal-directed autonomy. Research published in Frontiers in Artificial Intelligence found that agentic architectures can reduce cognitive workload by up to 52 percent compared to traditional clinical decision support.1
The Enterprise Technology Landscape
The market is consolidating around major platforms. Microsoft’s healthcare agent orchestrator provides pre-configured agents for clinical trial matching and tumor board preparation. Epic Systems has deployed multiple AI agents: Emmie (patient engagement), Art (provider communications), and Penny (revenue cycle management).6
Table 1: Healthcare Agentic AI Platform Comparison (January 2026)
Pilot deployments; addresses evidence accessibility
Regulatory Landscape and Liability
The FDA’s database lists over 1,250 AI-enabled medical devices authorized for marketing, but the vast majority are narrow diagnostic imaging tools. True agentic systems for clinical decision-making face the most stringent Class III regulatory pathway.9
Fig. 3 FDA AI adoption timeline – Elsa launch (June 2025) through Agentic AI deployment (December 2025)
The liability landscape presents novel challenges. Traditionally, the “learned intermediary” doctrine shields device manufacturers when physicians exercise independent judgment. However, agentic systems that execute autonomously may eliminate this shield, exposing manufacturers to direct liability.12
Implementation Prioritization Framework
Table 2: Implementation Prioritization Framework
Phase
Use Cases
Risk Profile
Timeline
Immediate (2026)
Scheduling, prior auth, messaging triage
Low clinical risk
3-6 months
Near-term (2026-2027)
Ambient documentation, coding assistance
Moderate risk
6-12 months
Medium-term (2027-2028)
Clinical decision support, care coordination
Higher risk
12-24 months
Longer-term (2028+)
Autonomous monitoring, closed-loop systems
Highest risk
24+ months
References
Hinostroza Fuentes N, et al. Frontiers in Artificial Intelligence. 2025;8.
U.S. Food and Drug Administration. News Release. Dec 1, 2025.
HHS Artificial Intelligence Strategy. Dec 4, 2025.
IBM. What is Agentic AI? 2025.
Microsoft Build 2025 Announcement.
Healthcare IT News. Epic UGM 2025.
Microsoft Industry Blog. Nov 18, 2025.
PDA News Brief. Dec 2025.
Bipartisan Policy Center. Nov 10, 2025.
European Pharmaceutical Review. Jan 2026.
Manatt Health AI Policy Tracker. 2025.
Price WN, et al. JAMA. 2019;322(18):1765-1766.
Parasuraman R, Human Factors. 2010.
Longoni C, Journal of Consumer Research. 2019.
Medical Economics. Johns Hopkins study. 2025.
Health Affairs. 2014;33(9):1586-1594.
Gartner Top Strategic Trends 2025.
Microsoft Research Podcast. July 23, 2025.
About the Author
Dr. Srikanth Mahankali is a leading expert in the implementation of medical AI and policy. As CEO of Shree Advisory & Consulting and a member of the NSF/MITRE AI Workforce Working Group, he shapes national AI strategy while driving responsible innovation.
Why faster AI and prettier plans don’t solve inconsistency, risk, or scale in dental clinics
Over the past two years, artificial intelligence has moved rapidly into dental clinics. Treatment plans can now be generated in seconds. Clinical findings are converted into polished patient-facing PDFs. Documentation that once consumed chairside or after-hours time has become dramatically faster.
From a speed and presentation perspective, this is real progress.
Yet many clinic owners, operators, and senior clinicians are quietly reporting the same frustration: despite faster planning and better presentation, the underlying problems inside clinics haven’t disappeared.
Treatment plans are still inconsistent. Decisions still vary between clinicians. Cases still stall before treatment begins. And scaling beyond individual expertise remains difficult.
The issue is not that AI tools don’t work. The issue is that plan generation and clinical decision-making are not the same problem.
AI solved generation — not decisions
Most current AI systems in dentistry are excellent at generation. They summarize findings, propose options, and structure plans based on input data. They reduce manual effort and improve clarity compared to handwritten notes or fragmented documentation.
But generation answers a different question than the one clinics actually struggle with.
AI answers: “What could be done?”
Clinics struggle with: “Which option should we choose, why, and how do we remain consistent across cases and clinicians?”
That distinction matters more than it seems.
Generation ≠ decision-making
A treatment plan is not just a list of procedures. It is a decision embedded in a broader context of:
Two clinicians can receive the same AI-generated plan and make different decisions about what to present, prioritize, or defer. Neither is necessarily wrong — but the clinic now carries variation that is rarely visible until something goes wrong.
AI tools do not resolve this variation. They often amplify it, by producing plausible options without enforcing decision logic.
A clinic vignette: when AI makes inconsistency visible
Consider a multi-chair general practice that recently adopted an AI-assisted planning and presentation tool across all clinicians. Within weeks, management noticed something unexpected.
Two patients with nearly identical profiles — moderate periodontal findings, early carious lesions, and signs of erosive wear — were seen by different clinicians. Both plans were generated using the same AI system. The layouts were clean. The language was professional.
The documentation looked standardized. Yet the substance of the plans differed markedly.
One plan emphasized immediate periodontal stabilization and conservative monitoring. The other prioritized restorative treatment with a more aggressive intervention sequence. Case acceptance, chairtime estimates, and projected costs varied significantly. No clear clinical error was identified. Each plan could be defended.
What the AI exposed was not a software flaw — but the absence of a shared decision framework behind those choices.
Where inconsistency appears — before treatment even begins
Most treatment failures are not technical failures. They occur before treatment starts. Clinic operators recognize these patterns immediately:
Cases accepted but never scheduled
Patients pausing due to unclear priorities
Replanning the same case multiple times
Internal disagreement on the “best” approach
Clinicians second-guessing their own recommendations
These are not problems of skill. They are problems of decision coherence. When decision-making remains implicit and experience-driven, clinics depend on personal authority rather than shared structure. That works at small scale — and quietly breaks as complexity increases.
Why operators and DSOs feel this first
Individual clinicians can often function comfortably with implicit reasoning. Operators cannot. As clinics grow, operators face uncomfortable questions:
Why do similar cases produce different plans?
Why do some clinicians escalate risk faster than others?
Why does standardization feel restrictive rather than enabling?
Why does adding talent sometimes increase friction instead of performance?
These are not software problems. They are decision architecture problems. AI makes planning faster, but it does not make reasoning visible, comparable, or repeatable.
The missing layer: decision consistency
Decision consistency does not mean uniform treatment. It means that differences are intentional, explainable, and defensible. A consistent clinic can answer:
Why one option was chosen over alternatives
What risks were accepted or deferred
How a case aligns with clinic strategy
Where clinical judgment overrides automation
Without this structure, clinics rely on reassurance — not reasoning. Polished PDFs may calm patients. AI-generated plans may look confident. But none of this guarantees that decisions are aligned, scalable, or safe over time.
From automation to accountability
Dentistry is entering a post-AI phase faster than many realize. In this phase, plan generation is assumed, speed is expected, and presentation is table stakes.
The differentiator becomes how decisions are evaluated, compared, and repeated. AI can generate options. Only structured reasoning creates accountability. As regulatory scrutiny increases and clinics scale, the ability to explain why a decision was made will matter as much as what was done.
Decision consistency is not a luxury. It is the infrastructure that allows AI to be used safely, intelligently, and at scale.
Closing thought
The question dentistry now faces is not: “How do we generate better treatment plans?”
But rather: “How do we make better decisions — consistently, defensibly, and at scale?”
AI solved one layer. The next bottleneck is already here.
About the author
Dr. Sami Savolainen is a dentist and healthcare systems thinker working at the intersection of clinical decision-making, documentation, and risk management. With experience in clinical practice and system design, he focuses on how planning structures determine safety, trust, and scalability in modern healthcare.
Artificial intelligence is everywhere today — woven into nearly every aspect of life and conversation. But what is it exactly, what can it do, and more importantly, how can it serve you and your patients?
To understand its role, we should start with definitions. “Artificial” refers to something made by humans rather than occurring naturally, often designed to simulate the real thing. “Intelligence” describes the capacity to learn, reason, adapt, and solve problems — abilities central to understanding and navigating the world. The term “artificial” sometimes carries negative undertones, suggesting something insincere or unnatural, while the word “Augmented” implies enhancement — making something more complete, effective, or capable.
“Artificial intelligence” (AI) is a branch of computer science devoted to developing systems that perform cognitive tasks typically requiring human intellect, such as learning, reasoning, and decision-making. These systems process data, identify patterns, and make predictions that often emulate human thought.
“Augmented intelligence” (AI), by contrast, is human-centric, focusing on collaboration between humans and machines. Instead of replacing human expertise, it enhances it — using advanced analytics and vast computational power to support better judgments and outcomes. In dentistry, this distinction is essential. Our profession thrives on human empathy, intuition, and ethical care. Therefore, dentistry should embrace an augmented, rather than purely artificial, approach — one that integrates machine learning and diagnostic data with the clinician’s judgment and compassion.
Yet this integration raises vital ethical questions. Borrowing inspiration from Isaac Asimov’s “Three Laws of Robotics,” we might propose similar principles for dental AI:
It must never harm a patient;
it must follow human direction within that constraint; and
it must protect its data integrity without violating the first two rules.
Augmented intelligence is a powerful addition to modern dentistry — one that, used ethically and wisely, will amplify human intelligence, empowering both practitioner and patient.
Sincerely, George Freedman BSc, DDS, FIADFE, DiplABD, FAACD, FASDA, FPFA on behalf of the Artificial Intelligence Journal of Medicine and Dentistry (AIMEDENT Journal)
freedman6469@rogers.com
Clinical experience has limits, even in skilled hands. Clinical expertise remains a cornerstone of medical and dental practice. Years of training refine pattern recognition, inform diagnostic reasoning, and enable clinicians to navigate uncertainty in complex clinical environments. However, experience alone does not render clinicians immune to diagnostic error, particularly when disease presents with atypical features that fall outside classical descriptions. Diagnostic reasoning is also shaped by cognitive biases
that can unconsciously influence clinical interpretation over time, potentially delaying more definitive investigation.
A Routine Referral That Wasn’t Routine
A 60-year-old male patient with a long-standing history of smoking was referred for what appeared to be a routine dental implant consultation.
The referral did not raise immediate concern. However, clinical examination revealed a lesion on the lower lip that the patient reported had been appearing and resolving intermittently for nearly two years.
During that period, the patient had been assessed by both a medical doctor and a dentist. Because of its fluctuating presentation, the lesion was diagnosed as herpes simplex
and managed conservatively. No biopsy was undertaken. Over time, the lesion persisted and increased in size, and the patient became increasingly self-conscious, even wearing a mask in public to conceal its appearance.
When a Familiar Diagnosis Becomes a Blind Spot
On clinical assessment, the lesion’s characteristics were inconsistent with a benign viral condition. Its location, persistence, and the patient’s risk profile prompted urgent referral for biopsy. Histopathological analysis confirmed the diagnosis of lip melanoma, a rare but aggressive malignancy. The head and neck surgeon later indicated that had the diagnosis been further delayed by six to twelve months, the prognosis could have been significantly worse.
This case provides a clear example of anchoring bias, in which the initial diagnosis of herpes simplex influenced all subsequent clinical interpretations despite evolving evidence to the contrary. Anchoring bias is among the most frequently discussed cognitive biases in healthcare decision-making, affecting clinicians’ ability to revisit or revise diagnostic hypotheses when faced with new or discordant information.
Fig. 1 – Pre-treatment
Pre-treatment
Fig. 2 – Post-treatment
Post-treatment
Where AI Could Have Changed the Timeline
AI has the potential to intervene precisely at vulnerable points in the diagnostic process by providing objective pattern recognition that is independent of prior clinical assumptions. In dermatology and related domains, AI-based image analysis systems have demonstrated performance levels comparable to or exceeding those of experienced clinicians when trained on large, well-curated datasets.
In this case, while AI would not replace histopathological diagnosis—the gold standard—it could have flagged the lesion as atypical and prompted earlier biopsy referral. This earlier warning might have reoriented clinical reasoning sooner and reduced diagnostic delay.
Importantly, recent research shows that diversity and dataset quality are critical to AI performance. Models trained predominantly on lighter skin tones may underperform on other populations, underscoring the need for equitable data representation.
AI as a Clinical Safety Net
AI does not undermine clinical autonomy; instead, it serves as a safeguard against diagnostic inertia and cognitive blind spots. By introducing an objective analytical perspective, AI supports clinicians in identifying patterns that may be subtle or atypical, especially in early disease presentations or high-risk patient profiles.
AI functions as a “second set of eyes,” complementing human judgment and prompting re-evaluation when visual or contextual features do not align with benign expectations. This aligns with broader evidence that AI systems can enhance lesion classification and risk stratification when integrated into clinical workflows.
Seeing Risk Before It Becomes Obvious
This case raises important questions for contemporary clinical practice. How many serious conditions are delayed because they resemble common, low-risk presentations? How often does initial diagnostic familiarity reduce ongoing vigilance?
While early detection remains crucial for improving outcomes, early diagnostic doubt supported by objective tools like AI often makes timely intervention possible.
The future of healthcare will not be defined by clinicians or algorithms working in isolation. Human clinical reasoning, grounded in experience, context, and ethical judgment, must be augmented by AI’s capacity for large-scale pattern recognition and resistance to cognitive bias. Together, these strengths create a more resilient diagnostic framework.
In the case described, human clinical judgment ultimately altered the patient’s outcome. With AI integrated earlier into the diagnostic pathway, that judgment could have been supported much sooner.
References
Karimzadhagh S. et al. (2026). Performance of Artificial Intelligence in Skin Cancer Detection. International Journal of Dermatology, 65(1), 69–85.
Papachristou P. et al. (2024). AI decision support for melanoma detection in primary care. British Journal of Dermatology, 191(1), 125–133. https://doi.org/10.1093/bjd/ljae021
About the Author
Dr. Shervin Molayem is a California-based periodontist and co-founder of Trust AI, the first AI-native patient management system in dentistry. His work focuses on the oral-systemic connection, salivary diagnostics, and multimodal AI treatment planning. Dr. Molayem also serves as a board member, advisor, and investor in dental technology companies, helping accelerate innovation and modernize clinical care.
Dr. Ameed Khalid Abdul-Hamid is an Iraqi–British dental surgeon and academic researcher, internationally recognized for his contributions to artificial intelligence in dentistry and healthcare. He serves as Chairman of the Arab Organisation for Artificial Intelligence in Healthcare and Chairman of the Saudi-British Medical Forum (London). His research focuses on AI-enabled diagnostics, digital health systems, and the ethical, responsible integration of artificial intelligence in clinical care.
Sincerely,
Dr. Shervin Molayem is a California-based periodontist and co-founder of Trust AI, the first AI-native patient management system in dentistry. His work focuses on the oral-systemic connection, salivary diagnostics, and multimodal AI treatment planning. Dr. Molayem also serves as a board member, advisor, and investor in dental technology companies, helping accelerate innovation and modernize clinical care.
